Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-25-076866
Filing Date
2025-08-12
Accepted
2025-08-12 16:26:06
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3/A tm2522593-3_s3a.htm S-3/A 449121
2 EXHIBIT 5.1 tm2522593d4_ex5-1.htm EX-5.1 16685
3 EXHIBIT 5.2 tm2522593d4_ex5-2.htm EX-5.2 7432
4 EXHIBIT 23.3 tm2522593d4_ex23-3.htm EX-23.3 2003
5 EXHIBIT 25.1 tm2522593d4_ex25-1.htm EX-25.1 109118
6 GRAPHIC lg_verastemoncology-4c.jpg GRAPHIC 43292
7 GRAPHIC lg_cantor-4c.jpg GRAPHIC 10393
8 GRAPHIC tm2522593d4_ex25-1img03.jpg GRAPHIC 231157
9 GRAPHIC tm2522593d4_ex5-1img01.jpg GRAPHIC 6016
10 GRAPHIC tm2522593d4_ex5-2img02.jpg GRAPHIC 6840
  Complete submission text file 0001104659-25-076866.txt   996206
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-289399 | Film No.: 251207136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)